In an interview on CNBC’s Mad Money, TG Therapeutics CEO Michael Weiss said: We’ve had a string of nice results… In MS, we have a great value proposition… We can be very competitive on price since we’re a small company… We are targeting large markets.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.